News

Also Cue Health scores $13 million from the department of Health and Human Services Biomedical Advanced Research and Development authority in order to fund its portable COVID-19 diagnostic test.

The PPG-based feature automatically measures the wearer's heart rhythm every five minutes, and will be ready for integration with a range of devices later this year.

The round was led by Mosaik Partners, and will be used to grow PatientPay's product line. 

The proposal would fully fund telehealth services and devices for eligible healthcare providers, although some aren't pleased with its exclusion of for-profit hospitals.

The startup is working with national emergency services to remotely triage, support and manage infected people in isolation.

New @HomeVR modality makes accredited simulations available on standalone headsets. 

German-based Ralf Jahns, MD at Research2Guidance, explains the role of different stakeholders in fighting COVID-19.

Funds will be used to expand further and strengthen the startup’s medical network.

The device has already been used to successfully treat patients with the coronavirus  in Wuhan, China.

The AI company now has a presence among more than 500 U.S. hospitals.